D.E. Shaw & Co’s NEVRO CORP. NVRO Stock Holding History

D.E. Shaw & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$280K	–	4989
2024 Q3	$280K	Sell	50,000 -57,000	-53%	-$399K	﹤0.01%	4012
2024 Q2	$901K	Buy	107,000 +25,100	+31%	+$268K	﹤0.01%	3257
2024 Q1	$1.18M	Buy	+81,900	New	+$1.35M	﹤0.01%	2977
2022 Q3	–	Sell	-6,700	Closed	-$294K	–	5596
2022 Q2	$294K	Sell	6,700 -10,000	-60%	-$550K	﹤0.01%	4368
2022 Q1	$1.21M	Sell	16,700 -3,300	-17%	-$238K	﹤0.01%	3753
2021 Q4	$1.62M	Sell	20,000 -40,000	-67%	-$4.01M	﹤0.01%	3545
2021 Q3	$6.98M	Buy	+60,000	New	+$7.85M	0.01%	1812
2020 Q4	–	Sell	-12,900	Closed	-$1.8M	–	4205
2020 Q3	$1.8M	Hold	12,900	–	–	﹤0.01%	2479
2020 Q2	$1.54M	Hold	12,900	–	–	﹤0.01%	2615
2020 Q1	$1.29M	Buy	+12,900	New	+$1.55M	﹤0.01%	2538
2018 Q2	–	Sell	-5,200	Closed	-$451K	–	3930
2018 Q1	$451K	Buy	5,200 +200	+4%	+$16.1K	﹤0.01%	2938
2017 Q4	$345K	Buy	+5,000	New	+$400K	﹤0.01%	3176

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

D.E. Shaw & Co's NVRO Position: Q2 2025 in Review

D.E. Shaw & Co sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 1,251,830 shares — an estimated $7.31M sold.

D.E. Shaw & Co first reported a position in NVRO in Q2 2015 and held it in 35 quarters. The position peaked at $227M in Q4 2019. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

D.E. Shaw & Co reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
D.E. Shaw & Co sold 1,251,830 NEVRO CORP. shares in Q2 2025, an estimated $7.31M.
D.E. Shaw & Co first reported a position in NEVRO CORP. in Q2 2015 and held it in 35 quarters.
D.E. Shaw & Co's NEVRO CORP. position peaked at $227M in Q4 2019.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.